Table 1. Baseline characteristics of the study population.
| Characteristics | N = 200 |
|---|---|
| Age, year, mean ± SD | 59.7 ± 9.2 |
| Sex, male | 182 (91.0%) |
| Etiologies of liver disease | |
| Alcohol | 24 (12.0%) |
| HBV | 137 (68.5%) |
| HCV | 17 (8.5%) |
| Others | 22 (11.0%) |
| Laboratory findings | |
| Platelet count§, x1000/mm3 | 163.0 [116.5–206.5] |
| Serum albumin§, g/dL | 3.5 [3.2–3.8] |
| Bilirubin§, mg/dL | 0.6 [0.5–0.9] |
| Prothrombin time§, % | 86.1% [77.3%-95.1%] |
| INR§ | 1.1 [1.0–1.1] |
| ALT§, IU/L | 35 [24–53] |
| Child-Pugh score | |
| 5–6 | 178 (89.0%) |
| 7–8 | 22 (11.0%) |
| MELD score | 7 [7–9] |
| Number of tumors | |
| 1 | 39 (19.5%) |
| 2 | 49 (24.5%) |
| 3 | 31 (15.5%) |
| ≥4 | 81 (40.5%) |
| Tumor size, mean ± SD, cm | |
| Largest | 6.8 ± 4.3 |
| Second largest† | 2.6 ± 2.3 |
| Third largest‡ | 1.5 ± 0.8 |
| Outside Milan criteria | 200 (100.0%) |
| Up to seven criteria | |
| Within up-to-seven criteria | 48 (24.0%) |
| Beyond up-to-seven criteria | 152 (76.0%) |
| Alpha-fetoprotein, ng/mL | |
| Median | 49.5 [10.0–508.0] |
| ≤200 | 66 (33.0%) |
| >200 | 134 (67.0%) |
†161 patients with multiple tumors
‡112 patients with number of tumors >2
§Numbers are presented as median and numbers in brackets are the interquartile ranges
HBV: hepatitis B virus, HCV: hepatitis C virus, SD: standard deviation